EP Patent

EP3736015A1 — Multi-unit drug delivery devices and methods

Assigned to Taris Biomedical LLC · Expires 2020-11-11 · 6y expired

What this patent protects

The present invention relates to an intravesical drug delivery device comprising:a first housing portion loaded with a drug formulation which comprises a drug; and a second housing portion loaded with an excipient, wherein the device is configured to release the drug according to…

USPTO Abstract

The present invention relates to an intravesical drug delivery device comprising:a first housing portion loaded with a drug formulation which comprises a drug; and a second housing portion loaded with an excipient, wherein the device is configured to release the drug according to a first release profile and is configured to release the excipient according toa second release profile which differs from the first release profile.

Drugs covered by this patent

Patent Metadata

Patent number
EP3736015A1
Jurisdiction
EP
Classification
—
Expires
2020-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Taris Biomedical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.